Drug Profile
BMY 20862
Alternative Names: BMS 183729Latest Information Update: 23 Aug 1995
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Anti-ischaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Stroke
Most Recent Events
- 23 Aug 1995 Discontinued-Preclinical for Stroke in USA (Unknown route)